Truist Financial’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$589K Sell
26,453
-3,381
-11% -$80.8K ﹤0.01% 1984
2025
Q4
$797K Buy
29,834
+4,057
+16% +$96.9K ﹤0.01% 1790
2025
Q3
$550K Sell
25,777
-11,064
-30% -$262K ﹤0.01% 1975
2025
Q2
$795K Sell
36,841
-2,474
-6% -$46K ﹤0.01% 1717
2025
Q1
$653K Sell
39,315
-10,303
-21% -$187K ﹤0.01% 1726
2024
Q4
$910K Sell
49,618
-4,965
-9% -$80.1K ﹤0.01% 1597
2024
Q3
$839K Buy
54,583
+4,577
+9% +$76.4K ﹤0.01% 1617
2024
Q2
$813K Buy
50,006
+6,887
+16% +$111K ﹤0.01% 1709
2024
Q1
$797K Sell
43,119
-20,807
-33% -$515K ﹤0.01% 1726
2023
Q4
$2M Sell
63,926
-32,824
-34% -$784K ﹤0.01% 1257
2023
Q3
$2.02M Buy
96,750
+32,068
+50% +$871K ﹤0.01% 1238
2023
Q2
$1.55M Buy
64,682
+20,357
+46% +$452K ﹤0.01% 1371
2023
Q1
$834K Buy
44,325
+6,539
+17% +$125K ﹤0.01% 1663
2022
Q4
$602K Sell
37,786
-4,082
-10% -$63.8K ﹤0.01% 1832
2022
Q3
$685K Sell
41,868
-7,513
-15% -$122K ﹤0.01% 1659
2022
Q2
$696K Sell
49,381
-12,016
-20% -$224K ﹤0.01% 1719
2022
Q1
$1.49M Sell
61,397
-20,861
-25% -$505K ﹤0.01% 1429
2021
Q4
$1.92M Sell
82,258
-21,742
-21% -$437K ﹤0.01% 1315
2021
Q3
$1.73M Buy
104,000
+16,973
+20% +$327K ﹤0.01% 1345
2021
Q2
$2.12M Buy
87,027
+11,390
+15% +$257K ﹤0.01% 1262
2021
Q1
$1.95M Buy
75,637
+32,911
+77% +$1.45M ﹤0.01% 1253
2020
Q4
$2.28M Buy
42,726
+13,358
+45% +$663K ﹤0.01% 1117
2020
Q3
$1.21M Buy
29,368
+13,002
+79% +$561K ﹤0.01% 1294
2020
Q2
$793K Buy
16,366
+2,054
+14% +$98.6K ﹤0.01% 1390
2020
Q1
$605K Buy
14,312
+1,211
+9% +$49.9K ﹤0.01% 1481
2019
Q4
$561K Buy
+13,101
New +$570K ﹤0.01% 1770
2017
Q4
Sell
-5,836
Closed -$220K 791
2017
Q3
$220K Buy
+5,836
New +$190K ﹤0.01% 738

Other funds holding ACAD